Dana Vigier, VP and Central and Northern Europe Area Head at Alexion, AstraZeneca Rare Disease, shares her views on a holistic approach to rare diseases. She emphasises the importance of listening to the voices of rare disease patients and ensuring they have access to the best treatment options.
In an exclusive interview with Michelle Melka, Director of Global Product Strategy, Digital Transformation at BioMarin, we delve into the changing landscape of pharmaceutical marketing. Melka emphasizes the importance of a patient-centric approach and highlights how BioMarin is evolving its digital capabilities to meet customer preferences. Learn about the challenges faced in providing accurate and accessible information, especially in the realm of rare diseases. Melka also discusses the company’s ambitions for powerful digital transformation and the future of content and omnichannel strategies in building meaningful relationships with healthcare professionals. Don’t miss the insights from this industry leader as she shares her vision for the future of pharma marketing.
Interview with Philip Pisa, Director, Digital Marketing and Innovation at Roche “The best omnichannel strategy is the one that it is actually possible to implement,” says Philip Pisa, Director, Digital Marketing and Innovation at Roche. Philip will attend the Reuters Pharma Customer Engagement Europe 2023 event, which runs from 9–10 November in London, and will …
Interview with Panos Papakonstantinou, Global Engagement Catalyst Leader at Roche Panos Papakonstantinou, the Global Engagement Catalyst Leader at Roche, will speak at November’s NEXT Pharma CX & Engagement Summit 2023 in Vienna, Austria, in a session entitled ‘Unlocking the power of CX for authentic and meaningful engagements.’ SciencePOD had the opportunity to speak with Panos …
Artificial Intelligence (AI) is set to be the future of research productivity, with a focus on ‘extractive summarisation’ for time-saving benefits. SciencePOD’s ScioWire Widget, as explained by CEO Sabine Louët, utilises AI to provide structured research summaries in a customisable newsfeed format. This innovative tool offers ‘augmented insights’ for individual publications and enhances the attractiveness and impact of journals. The ScioWire beta system generates newsfeeds that condense complex studies into accessible, brief summaries, thus aiding scientists in deciding the relevance of full text studies.
What sets these summaries apart is the contextual layer they provide, offering main keywords, definitions of technical terms and the answers to key study questions. This, coupled with the extractive summarisation technique, preserves the research’s integrity and avoids AI-related ‘hallucinations’. The ScioWire beta Widget can be embedded in third-party websites, bringing customised research directly to the professionals who need it. Highly adjustable, it offers automated translations and the ability to create personalised feeds for users and organisations alike. As Louët affirms, the future of research summarisation is tied to advances in natural language processing and machine learning, with AI set to revolutionise research accessibility and impact.
Rémi Quirion, Quebec’s Chief Scientific Adviser, is advocating for more widespread scientific advice at the municipal level to better serve citizens during emergency situations such as pandemics and climate change-related disasters. He proposes creating scientist-in-residence positions and training programs for scientific advice in municipalities. With proximity being essential, having scientific advisers at the municipal level will help citizens better understand the steps they can take to mitigate environmental issues. Quirion’s work in creating a North American chapter of the International Network of Science Advisors to Governments (INGSA) is a significant step towards increasing the delivery of scientific advice to cities. Overall, Quirion’s approach is an innovative solution to better serve citizens during times of crisis.
John Wahba, Medical Head of the Global Digital Hub at GSK, is scheduled to speak at the NEXT Pharma Summit in Dubrovnik, 16-17 May 2023, in a session entitled OMG (Omnichannel Medical Goals) – Mastering our Medical Capabilities and Insights.
SciencePOD had the opportunity to speak with John ahead of his session about the challenges in engaging healthcare professionals (HCPs) in personalized, informative and useful ways and the best ways to overcome these hurdles.
SciencePOD spoke with Kasper ahead of the NEXT Pharma Summit (Dubrovnik, 16-17 May 12023) where he will be participating in a panel discussion entitled Past, Present, Future – what is the trajectory for digital engagement in Pharma?
SciencePOD spoke with seasoned science journalist Michele Catanzaro in advance of WCSJ 2023 where he is participating in a panel discussion entitled How do journalists go beyond communicating risk to sharing risk know-how with communities? along with Tracey Brown, Bernard Okebe, and Sumaiya Shaikh.
One of the key takeaways from this year’s conference was the need for connection and facilitation, with more people focused on improving access to information and to key decision makers. There are promising signs, though.